awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50111623-219A7FFF-DCCE-4540-A8DD-5E2687E7A627
Q50111623-219A7FFF-DCCE-4540-A8DD-5E2687E7A627
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50111623-219A7FFF-DCCE-4540-A8DD-5E2687E7A627
A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis.
P2860
Q50111623-219A7FFF-DCCE-4540-A8DD-5E2687E7A627
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50111623-219A7FFF-DCCE-4540-A8DD-5E2687E7A627
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b760cabf253664667b513cc7472a2e44ff532a9f
P2860
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial